Samsung Bioepis Bevacizumab Nod Sets Stage For EU Throwdown

Aybintio Joins Amgen And Pfizer Avastin Rivals Ready For Expiry

 
• By Dave Wallace

Samsung Bioepis has received a pan-European endorsement from the CHMP for its Aybintio bevacizumab biosimilar. The nod follows two previous European Avastin biosimilar approvals, with market formation believed to be imminent.

EU boxing gloves
Multiple bevacizumab biosimilars could launch upon market formation • Source: Shutterstock

More from Biosimilars

More from Products